Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ahmed E. Goda"'
Autor:
Toshiyuki Sakai, Miki Wakada, Shusuke Yasuda, Ahmed E. Goda, Kimihiro Yano, Tatsushi Yoshida, Mano Horinaka, Hiroya Taniguchi
PDF file, 77K, ROS is not involved in the apoptosis induced by methylglyoxal with TRAIL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351eb56df5c1453e8dd5298308967399
https://doi.org/10.1158/1535-7163.22498057.v1
https://doi.org/10.1158/1535-7163.22498057.v1
Autor:
Toshiyuki Sakai, Miki Wakada, Shusuke Yasuda, Ahmed E. Goda, Kimihiro Yano, Tatsushi Yoshida, Mano Horinaka, Hiroya Taniguchi
Methylglyoxal is an essential component in glycolysis and is known to be an inducer of apoptosis. Glyoxalase I (GLO1) metabolizes and inactivates methylglyoxal. GLO1 is known to be overexpressed in cancer cells and causes resistance to anticancer age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b07cabc7be41864f544c05dec1b0136
https://doi.org/10.1158/1535-7163.c.6535780.v1
https://doi.org/10.1158/1535-7163.c.6535780.v1
Autor:
Toshiyuki Sakai, Miki Wakada, Shusuke Yasuda, Ahmed E. Goda, Kimihiro Yano, Tatsushi Yoshida, Mano Horinaka, Hiroya Taniguchi
PDF file, 171K, Expression of TRAIL receptors when treated with methylglyoxal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0105f39aa949f35bbbd1119ed783ec75
https://doi.org/10.1158/1535-7163.22498060
https://doi.org/10.1158/1535-7163.22498060
Autor:
Toshiyuki Sakai, Yoshihiro Sowa, Shingo Yogosawa, Miki Wakada, Yoshitaka Nakamura, Jun Fujiwara, Mitsuhiro Tomosugi, Mano Horinaka, Taka-aki Matsui, Ahmed E. Goda, Yasuyuki Izutani, Makoto Koyama
Purpose: The clinically relevant histone deacetylase inhibitors (HDI) valproic acid (VPA) and suberoylanilide hydroxamic acid exert variable antitumor activities but increase therapeutic efficacy when combined with other agents. The natural endogenou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0e536873a8bd7f72836679836680ba
https://doi.org/10.1158/1078-0432.c.6517632.v1
https://doi.org/10.1158/1078-0432.c.6517632.v1
Autor:
Toshiyuki Sakai, Yoshihiro Sowa, Shingo Yogosawa, Miki Wakada, Yoshitaka Nakamura, Jun Fujiwara, Mitsuhiro Tomosugi, Mano Horinaka, Taka-aki Matsui, Ahmed E. Goda, Yasuyuki Izutani, Makoto Koyama
Supplementary Data from Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fa2baacfd43bab2870164c2fc13f8bb
https://doi.org/10.1158/1078-0432.22440282
https://doi.org/10.1158/1078-0432.22440282
Autor:
Toshiyuki Sakai, Toshikazu Yoshikawa, Keisho Kataoka, Miki Wakada, Masako Konishi, Ahmed E. Goda, Takashi Yasuda, Mano Horinaka, Tatsushi Yoshida, Hiroya Taniguchi
Supplementary Figure 2 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af15439d207987c0e7a5a55a4bacac51
https://doi.org/10.1158/0008-5472.22375568
https://doi.org/10.1158/0008-5472.22375568
Autor:
Toshiyuki Sakai, Toshikazu Yoshikawa, Keisho Kataoka, Miki Wakada, Masako Konishi, Ahmed E. Goda, Takashi Yasuda, Mano Horinaka, Tatsushi Yoshida, Hiroya Taniguchi
Supplementary Figure 1 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fc04fd439ad63adb0a95d5f035c897
https://doi.org/10.1158/0008-5472.22375571.v1
https://doi.org/10.1158/0008-5472.22375571.v1
Autor:
Toshiyuki Sakai, Toshikazu Yoshikawa, Keisho Kataoka, Miki Wakada, Masako Konishi, Ahmed E. Goda, Takashi Yasuda, Mano Horinaka, Tatsushi Yoshida, Hiroya Taniguchi
Supplementary Figure 3 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc6f66e0e1addaca12f22785b0666db
https://doi.org/10.1158/0008-5472.22375565
https://doi.org/10.1158/0008-5472.22375565
Autor:
Toshiyuki Sakai, Toshikazu Yoshikawa, Keisho Kataoka, Miki Wakada, Masako Konishi, Ahmed E. Goda, Takashi Yasuda, Mano Horinaka, Tatsushi Yoshida, Hiroya Taniguchi
Supplementary Methods and Figure Legends 1-5 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb7b172ceb316a647e781e11cb4a636
https://doi.org/10.1158/0008-5472.22375553.v1
https://doi.org/10.1158/0008-5472.22375553.v1
Autor:
Toshiyuki Sakai, Toshikazu Yoshikawa, Keisho Kataoka, Miki Wakada, Masako Konishi, Ahmed E. Goda, Takashi Yasuda, Mano Horinaka, Tatsushi Yoshida, Hiroya Taniguchi
Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is one of the most promising candidates for new cancer therapeutics. A current problem is that some cancers still remain resistant to TRAIL. We show for the first time that a naturally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbc658bf0a7f33101f2a5e5994d6e4e7
https://doi.org/10.1158/0008-5472.c.6497867
https://doi.org/10.1158/0008-5472.c.6497867